Posts
October 02 2020
Vesper Healthcare Acquisition Corp. announced the closing of its initial public offering in the amount of $460,000,000. EGS acted as counsel to Vesper.
October 01 2020
BioLife Solutions, Inc. (“BioLife”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, announced the completion of the acquisition of SciSafe, a privately held multi-facility provider of biological materials storage to the cell and gene therapy and pharmaceutical industries. EGS acted as counsel to BioLife.
September 29 2020
FinTech Acquisition Corp. IV announced the closing of its initial public offering in the amount of $230,000,000. EGS acted as counsel to the underwriter.
September 28 2020
Peridot Acquisition Corp. announced the closing of its initial public offering in the amount of $300,000,000. EGS acted as counsel to the underwriter.
September 25 2020
Titan Pharmaceuticals, Inc. announced the pricing of their registered direct offering in the amount of $2,700,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in the offering.
September 23 2020
One Week to NYC Indoor Dining
Though it seemed like this day would never come, NYC restaurants are finally permitted to reopen for indoor dining on September 30, 2020.
Click here to read the alert.
April 06 2020
WEBINAR: Beyond COVID-19: The Path to IPO
Preparing for the Post COVID-19 IPO Wave.
This webinar is for companies looking to open paths to capital through the IPO process. In the concise 18 minute presentation, you will be guided through the main concerns and emerging considerations of the IPO process in a financial environment reshaped by the COVID-19 pandemic.
Richard Anslow and Wei Wang, members of the Firm, will be panelists.
Click here to register.
September 22 2020
PMV Consumer Acquisition Corp. announced the closing of its initial public offering in the amount of $175,000,000. EGS acted as counsel to the underwriter.